Gene expression signature of estrogen receptor α status in breast cancer

BackgroundEstrogens are known to regulate the proliferation of breast cancer cells and to modify their phenotypic properties. Identification of estrogen-regulated genes in human breast tumors is an essential step toward understanding the molecular mechanisms of estrogen action in cancer. To this end we generated and compared the Serial Analysis of Gene Expression (SAGE) profiles of 26 human breast carcinomas based on their estrogen receptor α (ER) status. Thus, producing a breast cancer SAGE database of almost 2.5 million tags, representing over 50,000 transcripts.ResultsWe identified 520 transcripts differentially expressed between ERα-positive (+) and ERα-negative (-) primary breast tumors (Fold change ≥ 2; p < 0.05). Furthermore, we identified 220 high-affinity Estrogen Responsive Elements (EREs) distributed on the promoter regions of 163 out of the 473 up-modulated genes in ERα (+) breast tumors. In brief, we observed predominantly up-regulation of cell growth related genes, DNA binding and transcription factor activity related genes based on Gene Ontology (GO) biological functional annotation. GO terms over-representation analysis showed a statistically significant enrichment of various transcript families including: metal ion binding related transcripts (p = 0.011), calcium ion binding related transcripts (p = 0.033) and steroid hormone receptor activity related transcripts (p = 0.031). SAGE data associated with ERα status was compared with reported information from breast cancer DNA microarrays studies. A significant proportion of ERα associated gene expression changes was validated by this cross-platform comparison. However, our SAGE study also identified novel sets of genes as highly expressed in ERα (+) invasive breast tumors not previously reported. These observations were further validated in an independent set of human breast tumors by means of real time RT-PCR.ConclusionThe integration of the breast cancer comparative transcriptome analysis based on ERα status coupled to the genome-wide identification of high-affinity EREs and GO over-representation analysis, provide useful information for validation and discovery of signaling networks related to estrogen response in this malignancy.

[1]  Li Deng,et al.  Differential expression in SAGE: accounting for normal between-library variation , 2003, Bioinform..

[2]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[3]  V. Laudet,et al.  Transcriptional activities of the orphan nuclear receptor ERR alpha (estrogen receptor-related receptor-alpha). , 1999, Molecular endocrinology.

[4]  Philip M. Long,et al.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[6]  D. Agard,et al.  Estrogen receptor pathways to AP-1 , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  C. Schneeberger,et al.  Production and actions of estrogens. , 2002, The New England journal of medicine.

[8]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[9]  Ji Huang,et al.  [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.

[10]  C. Klinge Estrogen receptor interaction with estrogen response elements. , 2001, Nucleic acids research.

[11]  S. Safe,et al.  Transcriptional Activation of Insulin-Like Growth Factor-Binding Protein-4 by 17β-Estradiol in MCF-7 Cells: Role of Estrogen Receptor-Sp1 Complexes. , 1999, Endocrinology.

[12]  F. Wieser,et al.  Anatomy of the estrogen response element , 2004, Trends in Endocrinology & Metabolism.

[13]  Guido Jenster,et al.  Venn Mapping: clustering of heterologous microarray data based on the number of co-occurring differentially expressed genes , 2003, Bioinform..

[14]  Keith Baggerly,et al.  Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression , 2004, Breast Cancer Research.

[15]  W. Godolphin,et al.  Survival with breast cancer: the importance of estrogen receptor quantity. , 1989, European journal of cancer & clinical oncology.

[16]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[17]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[18]  M. Dawson,et al.  Mitogenic Effect of Orphan Receptor TR3 and Its Regulation by MEKK1 in Lung Cancer Cells , 2003, Molecular and Cellular Biology.

[19]  Yasuyuki Shima,et al.  Regulation of dendritic maintenance and growth by a mammalian 7-pass transmembrane cadherin. , 2004, Developmental cell.

[20]  Chunlei Wu,et al.  Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis , 2004, Cancer.

[21]  K. Korach,et al.  The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling* , 2001, The Journal of Biological Chemistry.

[22]  Martin C Frith,et al.  Genomic targets of nuclear estrogen receptors. , 2004, Molecular endocrinology.

[23]  F. Berditchevski,et al.  Function of α3β1–Tetraspanin Protein Complexes in Tumor Cell Invasion. Evidence for the Role of the Complexes in Production of Matrix Metalloproteinase 2 (Mmp-2) , 1999, The Journal of cell biology.

[24]  Carsten O. Peterson,et al.  Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.

[25]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Yasuyuki Shima,et al.  Flamingo, a Seven-Pass Transmembrane Cadherin, Regulates Planar Cell Polarity under the Control of Frizzled , 1999, Cell.

[27]  John Calvin Reed,et al.  Conversion of Bcl-2 from Protector to Killer by Interaction with Nuclear Orphan Receptor Nur77/TR3 , 2004, Cell.

[28]  C. Hughes,et al.  Integration of the Non-genomic and Genomic Actions of Estrogen , 2002, The Journal of Biological Chemistry.

[29]  John H. White,et al.  Genome-wide identification of high-affinity estrogen response elements in human and mouse. , 2004, Molecular endocrinology.

[30]  V. Laudet,et al.  Transcriptional Activities of the Orphan Nuclear Receptor ERRα (Estrogen Receptor-Related Receptor-α) , 1999 .

[31]  Christos Sotiriou,et al.  Defining the galaxy of gene expression in breast cancer , 2002, Breast Cancer Research.

[32]  L. Ashman,et al.  Characterization of Integrin–Tetraspanin Adhesion Complexes: Role of Tetraspanins in Integrin Signaling , 1999 .

[33]  K. Lee,et al.  Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. , 2001, Cancer research.

[34]  M. Macleod,et al.  Effects of estrogen on global gene expression: identification of novel targets of estrogen action. , 2000, Cancer research.

[35]  V. Jordan,et al.  The biological role of estrogen receptors α and β in cancer , 2004 .

[36]  R. Spang,et al.  Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Grimmond,et al.  Cloning, mapping, and expression analysis of a gene encoding a novel mammalian EGF-related protein (SCUBE1). , 2000, Genomics.

[38]  Sven Bilke,et al.  The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. , 2003, Cancer research.

[39]  K. Mikoshiba,et al.  The Slp Homology Domain of Synaptotagmin-like Proteins 1–4 and Slac2 Functions as a Novel Rab27A Binding Domain* , 2002, The Journal of Biological Chemistry.

[40]  S. Colman,et al.  Identification of a Novel Family of Cell-surface Proteins Expressed in Human Vascular Endothelium* , 2002, The Journal of Biological Chemistry.